Kareim

New Support Being Created

NASDAQ:TTPH   None
Despite failure at drug trials, stock still ranked "strong buy" by TipRank's 60th best rated analyst and others. May be a an opportunity to buy Call LEAP

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。